Last reviewed · How we verify
Complicated Proteus UTI
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Tobi · Novartis
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug. - Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis. - Cystadane · Recordati
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Cefepim · University Hospital Tuebingen
- Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Nebcin · University Hospital, Lille
- Zymar · Allergan
- Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Noroxin
- Floxin
- Cipro · Bayer AG
- Cystadane · Mayo Clinic
- Ceftazidim · Tel-Aviv Sourasky Medical Center
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Clinical guidelines
- FDA label — 1L
Ceftazidime is indicated for the treatment of complicated urinary tract infections caused by Proteus spp., including Proteus mirabilis and indole-positive Proteus. - FDA label — 1L
Ceftazidime is indicated for the treatment of complicated urinary tract infections caused by Pseudomonas aeruginosa.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated Proteus UTI patent landscape — cliff calendar, originator estates, attackable patents
- Complicated Proteus UTI treatment landscape brief
- Complicated Proteus UTI treatment updates RSS
Frequently asked questions about Complicated Proteus UTI
What drugs treat Complicated Proteus UTI?
Tracked treatments include Ramycin, Tobi, Maxipime, Cystadane, Pipracil, Cefepim, Ciprofloxacine, Vantobra.
What is the treatment for Complicated Proteus UTI?
Standard treatment for Complicated Proteus UTI includes Ramycin, Tobi, Maxipime, Cystadane, Pipracil. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Complicated Proteus UTI?
FDA label publishes guidelines for Complicated Proteus UTI. 2 guideline references tracked.
Related
- Treatment landscape: Complicated Proteus UTI patent cliff · Complicated Proteus UTI CI report
- Treatment: Ramycin
- Treatment: Tobi · Novartis
- Treatment: Maxipime · Baxter
- Treatment: Maxipime · Baxter
- Treatment: Cystadane · Recordati
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing